Position in MRK
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,927,500
+$137,826 QoQ
Shares Held
15,000
+0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#1,612
of 3,769 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Raleigh Capital Management Inc. holds $16,702,583 across 11 Drug Manufacturers - General names. MRK ranks #5 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
18,091 | $4,552,419 | |
| 2 | PFE |
Pfizer Inc
|
114,644 | $2,760,627 | |
| 3 | SNY |
Sanofi
|
63,394 | $2,704,388 | |
| 4 | LLY |
ELI LILLY & Co
|
1,690 | $2,027,036 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
15,000 | $1,927,500 | |
| 6 | AMGN |
Amgen Inc
|
4,020 | $1,455,722 | |
| 7 | JNJ |
Johnson & Johnson
|
3,730 | $947,308 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,017 | $254,827 |
All Filings in MRK
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,927,500 | 15,000 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,789,674 | 14,878 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,206,911 | 11,466 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $453,305 | 5,401 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $485,646 | 6,135 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $565,488 | 6,300 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,284,684 | 12,914 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,529,766 | 13,471 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,610,390 | 13,008 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,679,591 | 12,729 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,334,186 | 12,238 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $1,260,519 | 12,244 | Shares | Sole | 2023-12-08 | |
| 2023-06-30 | $1,656,423 | 14,355 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,558,187 | 14,646 | Shares | Sole | 2023-05-22 | |
| 2022-12-31 | $2,421,039 | 21,821 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,456,056 | 28,519 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,614,116 | 28,673 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $2,167,514 | 26,417 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,742,256 | 22,733 | Shares | Sole | 2022-02-16 | |
| No filing history on record for this holder in this stock. | ||||||